Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Press Releases

ROSEN, A LEADING NATIONAL FIRM, Encourages Tingo Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TIO

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tingo Group, Inc. (NASDAQ: TIO) between December 1, 2022 and June 6, 2023, both dates inclusive (the “Class Period”), of the important August 7, 2023 lead plaintiff deadline. SO WHAT: If you […]

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRL

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of the important July 18, 2023 lead plaintiff deadline. SO […]

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DZS Inc. Investors with Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm – DZSI

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DZS Inc. (NASDAQ: DZSI) between March 10, 2023 and May 31, 2023, both dates inclusive (the “Class Period”), of the important August 14, 2023 lead plaintiff deadline in the securities class […]

James Absalom Elevated to Chief Commercial Officer – International at ZRG

LONDON and NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — ZRG Partners, a leading global talent firm backed by private equity firm RFE Investment Partners, today announced the promotion of London-based executive James Absalom to the position of Chief Commercial Officer – International. Absalom became part of ZRG when his previous firm that he founded […]

Curia Expands Cell Line Development Offering with CHOZN Platform

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and […]

Curia Expande Oferta de Desenvolvimento de Linha Celular com a Plataforma CHOZN

Curia fecha contrato de licenciamento com a MilliporeSigma para apoiar a produção de proteínas e anticorpos ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje a assinatura de um contrato de licenciamento com a MilliporeSigma, a divisão norte-americana de Ciências da Vida […]

Curia étend son offre de développement de lignées cellulaires avec la plateforme CHOZN

Curia signe un accord de licence avec MilliporeSigma pour soutenir la production de protéines et d’anticorps ALBANY, État de New York, 20 juin 2023 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, développement et fabrication en sous-traitance de premier plan, a annoncé aujourd’hui avoir signé un accord d’octroi de licence avec MilliporeSigma, l’entreprise nord-américaine de […]